Literature DB >> 23680466

Affecting coping: does neurocognition predict approach and avoidant coping strategies within schizophrenia spectrum disorders?

Rebecca MacAulay1, Alex S Cohen.   

Abstract

According to various diathesis-stress models of schizophrenia, life stress plays a defining role in the onset and course of schizophrenia-spectrum disorders. In this regard, individual differences in coping strategies and affective traits, variables related to the management and experience of stress, may play a large role in susceptibility to the disorder and symptom exacerbation. Furthermore, it has been posited that cognitive deficits may limit an individuals' ability to effectively respond to stressful situations. We investigated the relationships between attention, immediate memory, trait negative affect (NA), trait positive affect (PA) and specific coping strategies within three groups: chronic schizophrenia patients (n=27), psychometrically-defined schizotypy (n=89), and schizotypy demographically-matched controls (n=26). As hypothesized affective traits displayed predictable relationships with specific coping strategies, such that NA was associated with the greater use of avoidant coping strategies within the schizophrenia and schizotypy group, while PA was associated with greater use of approach coping styles within all groups. The schizotypy group reported significantly higher levels of NA and also greater use of avoidant coping strategies than both the control and schizophrenia group. As expected group differences were found in trait affect, coping strategies, and cognitive functioning. Importantly, these group differences remained significant even when demographic variables were entered as covariates. Contrary to our expectations, cognitive functioning displayed only a few tenuous relationships with coping strategies within the schizophrenia and schizotypy groups. Overall, results support the notion that affective traits and not cognitive functioning is the best predictor of approach and avoidant coping strategies.
© 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Affective traits; Attention; Avoidant and approach coping; Memory; Schizophrenia; Schizotypy

Mesh:

Year:  2013        PMID: 23680466     DOI: 10.1016/j.psychres.2013.04.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Association of Schizotypy With Dimensions of Cognitive Control: A Meta-Analysis.

Authors:  Maria Steffens; Inga Meyhöfer; Kaja Fassbender; Ulrich Ettinger; Joseph Kambeitz
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

2.  Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome.

Authors:  Marco Armando; Corrado Sandini; Maelle Chambaz; Marie Schaer; Maude Schneider; Stephan Eliez
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

3.  Avoidance Coping Partially Accounts for the Relationship Between Trauma-Related Shame and PTSD Symptoms Following Interpersonal Trauma.

Authors:  Jordyn M Tipsword; Jazmin L Brown-Iannuzzi; Alyssa C Jones; Jessica Flores; Christal L Badour
Journal:  Violence Against Women       Date:  2021-02-18

4.  Psychometric Properties of the Coping Inventory for Stressful Situations in Korean Adults.

Authors:  Yoonmi Choi; Eunsoo Moon; Je Min Park; Byung Dae Lee; Young Min Lee; Hee Jeong Jeong; Young In Chung
Journal:  Psychiatry Investig       Date:  2017-07-11       Impact factor: 2.505

5.  The Impact of Adverse Childhood Experiences on Coping Strategies in Schizophrenia Spectrum Disorders: A Case-Control Study.

Authors:  Justyna Kasznia; Aleksandra Pytel; Bartłomiej Stańczykiewicz; Jerzy Samochowiec; Katarzyna Waszczuk; Małgorzata Kulik; Agnieszka Cyran; Błażej Misiak
Journal:  Psychol Res Behav Manag       Date:  2021-08-24

6.  Coping strategies and self-stigma in patients with schizophrenia-spectrum disorders.

Authors:  Michaela Holubova; Jan Prasko; Radovan Hruby; Klara Latalova; Dana Kamaradova; Marketa Marackova; Milos Slepecky; Terezia Gubova
Journal:  Patient Prefer Adherence       Date:  2016-06-24       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.